Eli Lilly Total Liabilities 2010-2024 | LLY

Eli Lilly total liabilities for the quarter ending December 31, 2024 were $64.443B, a 21.26% increase year-over-year.

  • Eli Lilly total liabilities for 2024 were $64.443B, a 21.26% increase from 2023.
  • Eli Lilly total liabilities for 2023 were $53.143B, a 37.27% increase from 2022.
  • Eli Lilly total liabilities for 2022 were $38.714B, a 2.36% decline from 2021.

Eli Lilly Total Liabilities 2010-2024 | LLY

  • Eli Lilly total liabilities for 2024 were $64.443B, a 21.26% increase from 2023.
  • Eli Lilly total liabilities for 2023 were $53.143B, a 37.27% increase from 2022.
  • Eli Lilly total liabilities for 2022 were $38.714B, a 2.36% decline from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B